Quetiapine as an adjuvant for alcohol withdrawal delirium
Phase 3
- Conditions
- Health Condition 1: F102- Alcohol dependence
- Registration Number
- CTRI/2024/07/069766
- Lead Sponsor
- Dr Jeel Vasa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 18 to 60 years
Patients of either gender
Patients with alcohol dependance suffering alcohol withdrawal in delirium (ICD 10 criteria F10.4)
Exclusion Criteria
Ages less than 18 years, or more than 60 years.
Patients with comorbid intellectual disability, history of psychosis, dementia
Patients with symptoms of Wernicke’s encephalopathy showing ophthalmoplegia, ataxia on clinical examination
Patients with a QTc interval above 500 msecs
Patient with recent (less than 3 months) cardiac events
Patients with prior allergic reactions to Quetiapine
Patients with a history of extrapyramidal symptoms with use of Quetiapine.
Patients with suspected multifactorial causes for the onset of delirium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method